The therapeutic potential of CNPase was validated in a pressure overload-induced cardiac hypertrophy model by the myocardial introduction of AAV9-CNPase, which ameliorated cardiac hypertrophy, fibrosis, and dysfunction through increasing cardiac energy production. The gene discussed is CNP; the disease is cardiac hypertrophy.